# Angiogenesis Inhibitors and Hypertension: Clinical Aspects

> **NCT00511511** · — · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00511511
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511511, "Angiogenesis Inhibitors and Hypertension: Clinical Aspects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00511511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*